Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Potier

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Ebiomedicine|April 4, 2024
Enhanced resolution profiling in twins reveals differential methylation signatures of type 2 diabetes with links to its complicationsColette Christiansen, Louis Potier, Tiphaine C Martin, et al.
Diabetologia|August 21, 2020
Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]Bertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Diabetologia|May 31, 2020
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyBertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Diabetologia|July 4, 2020
Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyBertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Diabetologia|February 18, 2021
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO studyMatthieu Wargny, Louis Potier, Pierre Gourdy, et al.
European Journal of Endocrinology|June 4, 2021
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO studyBlandine Tramunt, Sarra Smati, Sandrine Coudol, et al.
European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Ebiomedicine|April 4, 2024
Enhanced resolution profiling in twins reveals differential methylation signatures of type 2 diabetes with links to its complicationsColette Christiansen, Louis Potier, Tiphaine C Martin, et al.
Diabetologia|August 21, 2020
Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter]Bertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Diabetologia|May 31, 2020
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyBertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Diabetologia|July 4, 2020
Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO studyBertrand Cariou, Samy Hadjadj, Matthieu Wargny, et al.
Diabetologia|February 18, 2021
Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO studyMatthieu Wargny, Louis Potier, Pierre Gourdy, et al.
European Journal of Endocrinology|June 4, 2021
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO studyBlandine Tramunt, Sarra Smati, Sandrine Coudol, et al.
European Journal of Preventive Cardiology|May 16, 2024
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regionsSteven H J Hageman, Stephen Kaptoge, Tamar I de Vries, et al.
Pageof 10